News Conference News ESC 2025 ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients Michael O'Riordan September 10, 2025
News Conference News ESC Heart Failure 2025 TITRATE-HF: Use of GDMT for HF Is Getting Better but Still Not Ideal Todd Neale May 21, 2025
News Conference News AHA 2024 ARNI Lessens Anthracycline Cardiotoxicity in High-Risk Patients: SARAH Caitlin E. Cox November 18, 2024
News Conference News AHA 2024 One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024 Shelley Wood November 14, 2024
News Conference News ACC 2023 STOP-CA: Atorvastatin Curbs Heart Function Decline During Chemotherapy L.A. McKeown March 04, 2023
News Conference News ESC 2022 First Cardio-Oncology Guidelines From ESC Cover ‘Tremendous’ Territory L.A. McKeown August 26, 2022
News Conference News ACC 2020 Statins May Have Protective Effect on Chemotherapy-Induced Cardiotoxicity Yael L. Maxwell March 19, 2020
News Conference News SCCT 2019 Sex-Specific ‘Inventory’ Needed to Spot Key CVD Risk Factors in Women Yael L. Maxwell July 12, 2019
News Conference News SCAI 2019 Cancer and CV Disease Care: What’s Known? What Lies Ahead for Cardio-Oncology? Yael L. Maxwell May 30, 2019
News Conference News HRS 2019 Cancer Survivors With Heart Failure Respond Well to CRT Todd Neale May 14, 2019
News Conference News TCT 2016 Cancer Patients Face Increased Risk of Acute MI, More PCI Complications, Higher Mortality, and Soaring Costs Michael H. Wilson October 31, 2016